Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

South and Central America Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Technology ; Application, and Country

Published by The Insight Partners Product code 979188
Published Content info 118 Pages
Delivery time: 1-2 business days
Price
Back to Top
South and Central America Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Technology ; Application, and Country
Published: November 13, 2020 Content info: 118 Pages
Description

The South and Central America liposome drug delivery market is expected to reach US$ 206.29 million by 2027 from US$ 116.72 million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020 to 2027.

The liposome drug delivery market is growing primarily due to the Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.

The Liposome are novel drug delivery system (NDDS) , they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.

Over the past few decades, research and development (R&D) in liposomal drug delivery systems is increasing across the world due to increasing prevalence of chronic disease. Drug delivery is the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Liposomal drug delivery offers various advantages such as improved pharmacokinetics and pharmacodynamics, enhanced therapeutic efficacy, and decreased toxicity making these delivery systems ideal for patients suffering from various chronic conditions.

Liposomes are rapidly gaining acceptance as nano-carriers for various pharmaceutical applications. Compositions of cholesterol and phospholipids are becoming increasingly useful in liposome drug delivery. As the nanoscience is optimizing liposome drug delivery, the pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol as well as new techniques such as nanotechnology to improve the stability and drug release profiles with the help of encapsulation and other techniques. They are using liposomes for the generation of extracellular vesicles by targeted cells.

Manufacturers in the liposome drug delivery market are ramping up their R&D activities in order to unlock new lipid compositions and strategies that help to optimize the drug transport and stability of liposomes.

Research institutes, pharmaceutical, and biotech companies are now focusing in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from their regular supply of liposome drug delivery. Majority of the companies which are operating in the manufacturing segment of liposome drug delivery products are currently working on various therapeutic segment to tackle the pandemic situation. In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases. The COVID-19 outbreak highlights potential vulnerabilities in both our drug supply chain and clinical infrastructure, including the availability of adequate clinician resources..

Some of the significant secondary sources for automated compounding systems market included in the report are the Food and Drug Administration (FDA), World Health Organization (WHO).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America Liposome Drug Delivery market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America Liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00016262

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South and Central America Liposome Drug Delivery Market - By Product
    • 1.3.2 South and Central America Liposome Drug Delivery Market - By Technology
    • 1.3.3 South and Central America Liposome Drug Delivery Market - By Application
    • 1.3.4 South and Central America Liposome Drug Delivery Market - By Geography

2. South and Central America Liposome Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South and Central America Liposome Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Liposome Drug Delivery Market - South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. South and Central America Liposome Drug Delivery Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Involved in Development of Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Liposome Drug Delivery Market - South and Central America Analysis

  • 6.1 South and Central America Liposome Drug Delivery Market Revenue Forecasts and Analysis

7. South and Central America Liposome Drug Delivery Market Analysis and Forecasts To 2027 - By Product Overview

  • 7.1 South and Central America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)
    • 7.1.1 South and Central America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
  • 7.2 Liposomal Doxurubicin
    • 7.2.1 Overview
    • 7.2.2 South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.3 Liposomal Paclitaxel
    • 7.3.1 South and Central America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Liposomal Amphotericin B
    • 7.4.1 overview
    • 7.4.2 South and Central America Liposomal Amphotericin B forecast and market revenue
  • 7.5 Others
    • 7.5.1 overview
    • 7.5.2 South and Central America Other Liposome Drug Delivery Market overview and forecast to 2027

8. South and Central America Liposome Drug Delivery Market - By Technology

  • 8.1 Overview
  • 8.2 South and Central America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • 8.3 Stealth Liposome Technology
    • 8.3.1 Overview
    • 8.3.2 South and Central America Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Non-PEGylated Liposome Technology
    • 8.4.1 Overview
    • 8.4.2 South and Central America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DepoFoam Liposome Technology
    • 8.5.1 Overview
    • 8.5.2 South and Central America DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
    • 8.6.1 Overview
    • 8.6.2 South and Central America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. South and Central America Liposome Drug Delivery Market - By Application

  • 9.1 Overview
  • 9.2 South and Central America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • 9.3 Fungal Diseases
    • 9.3.1 Overview
    • 9.3.2 Fungal Diseases: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Cancer Therapy
    • 9.4.1 Overview
    • 9.4.2 Cancer Therapy: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Pain Management
    • 9.5.1 Overview
    • 9.5.2 Pain Management: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Viral Vaccine
    • 9.6.1 Overview
    • 9.6.2 Viral Vaccine: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Photodynamic Therapy
    • 9.7.1 Overview
    • 9.7.2 Photodynamic Therapy: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. South and Central America Liposome Drug Delivery Market - Geographic Analysis

  • 10.1 South and Central America : Liposome Drug Delivery Market
    • 10.1.1 Overview
    • 10.1.2 South and Central America : Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 South and Central America : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 Brazil : Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 Brazil:Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 Brazil: Liposome Drug Delivery market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 Brazil: Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Argentina : Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Argentina :Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Argentina: Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Argentina: Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic On South and Central America Liposome Drug Delivery Market

  • 11.1 South and Central America : Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Takeda Pharmaceutical Company Limited
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.3 Novartis AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.5 Luye Pharma Group
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Johnson & Johnson Services, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Ipsen Pharma
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Word Index

List Of Tables

  • Table 1. R&D Investments by major pharmaceutical companies
  • Table 2. South and Central America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
  • Table 3. South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 4. South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 5. South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Brazil Liposome Drug Delivery market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 12. List of Abbreviation

List Of Figures

  • Figure 1. Liposome Drug Delivery Market Segmentation
  • Figure 2. South and Central America Liposome Drug Delivery Segmentation : By Region
  • Figure 3. South and Central America Liposome Drug Delivery Market Overview;
  • Figure 4. Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market
  • Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period.
  • Figure 6. Liposome Drug Delivery Market - South and Central America PEST Analysis
  • Figure 7. South and Central America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
  • Figure 8. South and Central America Liposome Drug Delivery Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. South and Central America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)
  • Figure 10. South and Central America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 11. South and Central America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. South and Central America Liposomal Amphotericin B market revenue and forecast to 2027
  • Figure 13. South and Central America Other Liposome Drug Delivery Market overview and forecast to 2027
  • Figure 14. South and Central America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • Figure 15. South and Central America Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. South and Central America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. South and Central America DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. South and Central America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. South and Central America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • Figure 20. Fungal Diseases: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Cancer Therapy: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Pain Management: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Viral Vaccine: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Photodynamic Therapy: South and Central America Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. South and Central America : Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 26. South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 27. South and Central America : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 28. Brazil : Liposome Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Argentina : Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Impact of COVID-19 Pandemic In South and Central America Country Markets
Back to Top